Search

Your search keyword '"Megens, Remco"' showing total 352 results

Search Constraints

Start Over You searched for: Author "Megens, Remco" Remove constraint Author: "Megens, Remco"
352 results on '"Megens, Remco"'

Search Results

1. Generation of complex bone marrow organoids from human induced pluripotent stem cells

2. Identification of a non-canonical chemokine-receptor pathway suppressing regulatory T cells to drive atherosclerosis

4. Neuroimmune cardiovascular interfaces control atherosclerosis

5. Targeting platelet-derived CXCL12 impedes arterial thrombosis

8. Heterocomplexes between the atypical chemokine MIF and the CXC-motif chemokine CXCL4L1 regulate inflammation and thrombus formation

9. T cells armed with C-X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours

10. Tissue Clearing Approaches in Atherosclerosis

13. Targeting a cell-specific microRNA repressor of CXCR4 ameliorates atherosclerosis in mice

14. Cell-specific and divergent roles of the CD40L-CD40 axis in atherosclerotic vascular disease

17. Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

18. Histone Deacetylase 9 Activates IKK to Regulate Atherosclerotic Plaque Vulnerability

19. Externalized histone H4 orchestrates chronic inflammation by inducing lytic cell death

20. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting

23. The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell Function

24. Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice

29. Endothelial Retargeting of AAV9 In Vivo

30. Tissue Clearing Approaches in Atherosclerosis

31. Properties and fate of human mesenchymal stem cells upon miRNA let-7f-promoted recruitment to atherosclerotic plaques.

32. Heterocomplexes between the Atypical Chemokine MIF and the CXC-Motif Chemokine CXCL4L1 Regulate Inflammation and Thrombus Formation

34. Endothelial Retargeting of AAV9 In Vivo

35. MIF-2/D-DT is an atypical atherogenic chemokine that promotes advanced atherosclerosis and hepatic lipogenesis

36. Heterocomplexes between the Atypical Chemokine MIF and the CXC-Motif Chemokine CXCL4L1 Regulate Inflammation and Thrombus Formation

37. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1

39. MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions

40. CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice

42. Designed CXCR4 mimic acts as a soluble chemokine receptor that blocks atherogenic inflammation by agonist-specific targeting

43. A MIF‐Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2

44. Autophagy unleashes noncanonical microRNA functions

45. Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans

46. Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis

47. Glycoprotein VI is not a Functional Platelet Receptor for Fibrin Formed in Plasma or Blood

48. Chemokines and galectins form heterodimers to modulate inflammation

49. Tick Saliva Protein Evasin-3 Allows for Visualization of Inflammation in Arteries through Interactions with CXC-Type Chemokines Deposited on Activated Endothelium

50. PD-L1 expression on nonclassical monocytes reveals their origin and immunoregulatory function

Catalog

Books, media, physical & digital resources